503 related articles for article (PubMed ID: 12507132)
1. Basis of persistent and recurrent Cushing disease: an analysis of findings at repeated pituitary surgery.
Dickerman RD; Oldfield EH
J Neurosurg; 2002 Dec; 97(6):1343-9. PubMed ID: 12507132
[TBL] [Abstract][Full Text] [Related]
2. The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery.
Meij BP; Lopes MB; Ellegala DB; Alden TD; Laws ER
J Neurosurg; 2002 Feb; 96(2):195-208. PubMed ID: 11838791
[TBL] [Abstract][Full Text] [Related]
3. Prospective evaluation of the characteristics and incidence of adenoma-associated dural invasion in Cushing disease.
Lonser RR; Ksendzovsky A; Wind JJ; Vortmeyer AO; Oldfield EH
J Neurosurg; 2012 Feb; 116(2):272-9. PubMed ID: 21923247
[TBL] [Abstract][Full Text] [Related]
4. MR imaging of cavernous sinus involvement by pituitary adenomas.
Scotti G; Yu CY; Dillon WP; Norman D; Colombo N; Newton TH; De Groot J; Wilson CB
AJR Am J Roentgenol; 1988 Oct; 151(4):799-806. PubMed ID: 3262283
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of therapy for Cushing's disease due to adrenocorticotropin-secreting pituitary macroadenomas.
Blevins LS; Christy JH; Khajavi M; Tindall GT
J Clin Endocrinol Metab; 1998 Jan; 83(1):63-7. PubMed ID: 9435417
[TBL] [Abstract][Full Text] [Related]
6. Repeated transsphenoidal surgery to treat recurrent or residual pituitary adenoma.
Benveniste RJ; King WA; Walsh J; Lee JS; Delman BN; Post KD
J Neurosurg; 2005 Jun; 102(6):1004-12. PubMed ID: 16028758
[TBL] [Abstract][Full Text] [Related]
7. Aggressive transsphenoidal resection of tumors invading the cavernous sinus in patients with acromegaly: predictive factors, strategies, and outcomes.
Nishioka H; Fukuhara N; Horiguchi K; Yamada S
J Neurosurg; 2014 Sep; 121(3):505-10. PubMed ID: 25014437
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging after transsphenoidal surgery of clinically non-functional pituitary macroadenomas and its impact on detecting residual adenoma.
Kremer P; Forsting M; Ranaei G; Wüster C; Hamer J; Sartor K; Kunze S
Acta Neurochir (Wien); 2002 May; 144(5):433-43. PubMed ID: 12111499
[TBL] [Abstract][Full Text] [Related]
9. Endoscopic endonasal transsphenoidal approach for pituitary adenomas invading the cavernous sinus.
Ceylan S; Koc K; Anik I
J Neurosurg; 2010 Jan; 112(1):99-107. PubMed ID: 19480546
[TBL] [Abstract][Full Text] [Related]
10. Transsphenoidal surgery in Cushing disease: 10 years of experience in 34 consecutive cases.
Höybye C; Grenbäck E; Thorén M; Hulting AL; Lundblad L; von Holst H; Anggård A
J Neurosurg; 2004 Apr; 100(4):634-8. PubMed ID: 15070117
[TBL] [Abstract][Full Text] [Related]
11. Endoscopic endonasal transsphenoidal surgery for functional pituitary adenomas.
Hofstetter CP; Shin BJ; Mubita L; Huang C; Anand VK; Boockvar JA; Schwartz TH
Neurosurg Focus; 2011 Apr; 30(4):E10. PubMed ID: 21456921
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic transsphenoidal treatment in recurrent and residual pituitary adenomas--first experience.
Rudnik A; Zawadzki T; Gałuszka-Ignasiak B; Bazowski P; Duda I; Wojtacha M; Rudnik AI; Krawczyk I
Minim Invasive Neurosurg; 2006 Feb; 49(1):10-4. PubMed ID: 16547875
[TBL] [Abstract][Full Text] [Related]
13. The occurrence of dural invasion in pituitary adenomas.
Selman WR; Laws ER; Scheithauer BW; Carpenter SM
J Neurosurg; 1986 Mar; 64(3):402-7. PubMed ID: 3950720
[TBL] [Abstract][Full Text] [Related]
14. Repeat transsphenoidal surgery for Cushing's disease.
Friedman RB; Oldfield EH; Nieman LK; Chrousos GP; Doppman JL; Cutler GB; Loriaux DL
J Neurosurg; 1989 Oct; 71(4):520-7. PubMed ID: 2552045
[TBL] [Abstract][Full Text] [Related]
15. Cavernous sinus invasion by pituitary adenomas--relationship between magnetic resonance imaging findings and histologically verified dural invasion.
Daita G; Yonemasu Y; Nakai H; Takei H; Ogawa K
Neurol Med Chir (Tokyo); 1995 Jan; 35(1):17-21. PubMed ID: 7700477
[TBL] [Abstract][Full Text] [Related]
16. Reoperative endoscopic endonasal surgery for residual or recurrent pituitary adenomas.
Negm HM; Al-Mahfoudh R; Pai M; Singh H; Cohen S; Dhandapani S; Anand VK; Schwartz TH
J Neurosurg; 2017 Aug; 127(2):397-408. PubMed ID: 27791524
[TBL] [Abstract][Full Text] [Related]
17. [Transsphenoidal surgery of secretory and invasive pituitary adenomas (somatotropinoma or corticotropinoma)--own experiences].
Zieliński G; Podgórski JK; Koziarski A; Potakiewicz Z; Warczyńska A; Zgliczyński W; Makowska A
Przegl Lek; 2004; 61(9):928-34. PubMed ID: 15803901
[TBL] [Abstract][Full Text] [Related]
18. Pituitary magnetic resonance imaging findings do not influence surgical outcome in adrenocorticotropin-secreting microadenomas.
Salenave S; Gatta B; Pecheur S; San-Galli F; Visot A; Lasjaunias P; Roger P; Berge J; Young J; Tabarin A; Chanson P
J Clin Endocrinol Metab; 2004 Jul; 89(7):3371-6. PubMed ID: 15240617
[TBL] [Abstract][Full Text] [Related]
19. Invasion of the cavernous sinus space in pituitary adenomas: endoscopic verification and its correlation with an MRI-based classification.
Micko AS; Wöhrer A; Wolfsberger S; Knosp E
J Neurosurg; 2015 Apr; 122(4):803-11. PubMed ID: 25658782
[TBL] [Abstract][Full Text] [Related]
20. Maximizing the extent of tumor resection during transsphenoidal surgery for pituitary macroadenomas: can endoscopy replace intraoperative magnetic resonance imaging?
Theodosopoulos PV; Leach J; Kerr RG; Zimmer LA; Denny AM; Guthikonda B; Froelich S; Tew JM
J Neurosurg; 2010 Apr; 112(4):736-43. PubMed ID: 19835472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
